Immune cells were isolated from CRC samples (N=3) and TMEM123 expression was assessed by FACS analysis on the major subset populations, based on their immunologic function and cellular phenotyping expression: T, B and Natural Killer (NK) lymphocytes and myeloid cells. The gene discussed is TMEM123; the disease is colorectal carcinoma.